Medicare Advantage contract
H1032 Wellcare
Local CCP · Parent: Centene Corporation
⚠ Non-renewal
↓ Churn flag
Latest enrollment
65,932
2025-01
Year-over-year
-21.2%
contract book
National MA share
+0.1%
rank #123 of 936
Overall stars (latest)
★★★½ 3.5
summary rating
Enrollment trend · 5 years
Star rating history
| Year | Overall | Part C | Part D | Δ |
|---|---|---|---|---|
| 2020 | ★★★★ 4.0 | 3.5 | 4.0 | — |
| 2021 | ★★★★ 4.0 | 3.5 | 4.5 | — |
| 2022 | ★★★★½ 4.5 | 4.0 | 4.5 | +0.5 |
| 2023 | ★★★ 3.0 | 3.0 | 3.0 | -1.5 |
| 2024 | ★★★½ 3.5 | 3.5 | 4.0 | +0.5 |
Premium
Median monthly plan premium across this contract's plans, by year.
| Plan | Year | Monthly premium | Part D premium |
|---|---|---|---|
| H1032-193 | 2026 | $0.00 | $0.00 |
| H1032-194 | 2026 | $0.00 | $0.00 |
| H1032-195 | 2026 | $0.00 | $0.00 |
| H1032-196 | 2026 | $0.00 | $0.00 |
| H1032-198 | 2026 | $0.00 | $0.00 |
| H1032-199 | 2026 | $0.00 | $0.00 |
| H1032-200 | 2026 | $0.00 | $0.00 |
| H1032-201 | 2026 | $0.00 | $0.00 |
| H1032-202 | 2026 | $4.80 | $4.80 |
| H1032-204 | 2026 | $0.00 | $0.00 |
| H1032-205 | 2026 | $0.00 | $0.00 |
| H1032-210 | 2026 | $0.00 | $0.00 |
Showing 12 of 23 plans under this contract.
Premium analytics
Deeper cuts for investors and plan-strategy teams, delivered as a custom analysis.
Measure-level star movers
2023 → 2024- D04 Drug Plan Quality Improvement 1★ → 5★
- C25 Complaints about the Health Plan 1★ → 3★
- D06 Getting Needed Prescription Drugs 2★ → 4★
- C22 Rating of Health Care Quality 2★ → 4★
- C26 Members Choosing to Leave the Plan 1★ → 3★
- D01 Call Center Foreign Language Interpreter and TTY Availability 3★ → 5★
🔒 Want a custom analysis on this? — which measures moved, cut-point sensitivity, and
projected next-year exposure.
Talk to us →
County enrollment
0 counties| State | County | Enrollment |
|---|
Want a custom analysis on this?
Talk to us →County market share vs. competitors
service-area overlapHead-to-head share by county against named competitors, with expansion whitespace and defended turf.
Want a custom analysis on this?
Talk to us →